Results 1 to 10 of about 582,528 (311)

Trends and Costs of US Telehealth Use Among Patients With Cardiovascular Disease Before and During the COVID‐19 Pandemic

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The COVID‐19 pandemic affected outpatient care delivery and patients' access to health care. However, no prior studies have documented telehealth use among patients with cardiovascular disease.
Jun Soo Lee, Kincaid Lowe Beasley, Michael W. Schooley, Feijun Luo   +3 more
doaj   +1 more source

Social Determinants of Health–Related Z Codes and Health Care Among Patients With Hypertension

AJPM Focus, 2023
Introduction: Tracking social needs can provide information on barriers to controlling hypertension and the need for wraparound services. No recent studies have examined ICD-10-CM social determinants of health–related Z codes (Z55–Z65) to indicate social
Jun Soo Lee, PhD, Kara E. MacLeod, DrPH, Elena V. Kuklina, MD, PhD, Xin Tong, MPH, Sandra L. Jackson, PhD   +4 more
doaj   +1 more source

Changing Spatiotemporal Trends in County‐Level Heart Failure Death Rates in the United States, 1999 to 2018

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Amid recently rising heart failure (HF) death rates in the United States, we describe county‐level trends in HF mortality from 1999 to 2018 by racial/ethnic group and sex for ages 35 to 64 years and 65 years and older.
Adam S. Vaughan, Mary G. George, Sandra L. Jackson, Linda Schieb, Michele Casper   +4 more
doaj   +1 more source

Progress Toward Achieving National Targets for Reducing Coronary Heart Disease and Stroke Mortality: A County‐Level Perspective

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background The American Heart Association and Healthy People 2020 established objectives to reduce coronary heart disease (CHD) and stroke death rates by 20% by the year 2020, with 2007 as the baseline year.
Adam S. Vaughan, Rebecca C. Woodruff, Christina M. Shay, Fleetwood Loustalot, Michele Casper   +4 more
doaj   +1 more source

County‐Level Trends in Hypertension‐Related Cardiovascular Disease Mortality—United States, 2000 to 2019

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Amid stagnating declines in national cardiovascular disease (CVD) mortality, documenting trends in county‐level hypertension‐related CVD death rates can help activate local efforts prioritizing hypertension prevention, detection, and control ...
Adam S. Vaughan, Fátima Coronado, Michele Casper, Fleetwood Loustalot, Janet S. Wright   +4 more
doaj   +1 more source

Comparing Strategies to Prevent Stroke and Ischemic Heart Disease in the Tunisian Population: Markov Modeling Approach Using a Comprehensive Sensitivity Analysis Algorithm. [PDF]

, 2019
Background. Mathematical models offer the potential to analyze and compare the effectiveness of very different interventions to prevent future cardiovascular disease.
Bandosz, P, Capewell, S, Critchley, J, Guzman Castillo, M, Malouche, D, O'Flaherty, M, Romdhane, HB, Saidi, O, Zoghlami, N   +8 more
core   +1 more source

Million Hearts: Description of the National Surveillance and Modeling Methodology Used to Monitor the Number of Cardiovascular Events Prevented During 2012–2016

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background This study describes the national surveillance and modeling methodology developed to monitor achievement of the Million Hearts initiative's aim of preventing 1 million acute myocardial infarctions, strokes, and other related cardiovascular ...
Matthew D. Ritchey, Fleetwood Loustalot, Hilary K. Wall, Claudia A. Steiner, Cathleen Gillespie, Mary G. George, Janet S. Wright   +6 more
doaj   +1 more source

XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation. [PDF]

, 2014
Atrial fibrillation (AF) is associated with a fivefold increase in the risk of stroke. The Phase III ROCKET AF (Rivaroxaban Once-Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in ...
Amarenco, P, Camm, AJ, Haas, S, Hess, S, Kirchhof, P, Turpie, AG, van Eickels, M   +6 more
core   +2 more sources

Risk of Cardiovascular Disease After COVID‐19 Diagnosis Among Adults With and Without Diabetes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Growing evidence suggests incident cardiovascular disease (CVD) may be a long‐term outcome of COVID‐19 infection, and chronic diseases, such as diabetes, may influence CVD risk associated with COVID‐19.
Alain K. Koyama, Giuseppina Imperatore, Deborah B. Rolka, Elizabeth Lundeen, Rachel E. Rutkowski, Sandra L. Jackson, Siran He, Elena V. Kuklina, Soyoun Park, Meda E. Pavkov   +9 more
doaj   +1 more source

Adherence to secondary stroke prevention strategies - Results from the German stroke data bank [PDF]

, 2003
Only very limited data are available concerning patient adherence to antithrombotic medication intended to prevent a recurrent stroke. Reduced adherence and compliance could significantly influence the effects of any stroke prevention strategies.
Busse, O., Diener, H. C., Glahn, J., Hamann, Gerhard F., Weimar, C.   +4 more
core   +1 more source